Stopped: Re-evaluate indication with the referring physicians
To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Suspicious Lesions Identified by 18F FDOPA PET
Timeframe: Up to 30 minutes after injection of F18 FDOPA
Percent Agreement of 18F FDOPA PET With Pathology
Timeframe: Up to 30 minutes post-injection (at time of scan)